Skip to main content

Articles By Jonathan Kay, MD


Adalimumab Biosimilars: Realizing the Promise of Market Competition

Over four years after adalimumab biosimilars were first launched in the European Union and elsewhere, adalimumab biosimilars have finally become available in the United States. 

Read Article

New ACR RA Guidelines and Practice Changing Abstracts: RA Panel

Dr. Jonathan Kay leads an international panel discussion on the new ACR RA guidelines and several practice-changing abstracts presented at the 2020 ACR meeting. Panelists include Dr. Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes.

Read Article